Spots Global Cancer Trial Database for leukemia, lymphocytic
Every month we try and update this database with for leukemia, lymphocytic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Identifying Characteristics of Bone Marrow Failure Syndromes | NCT00315419 | Bone Marrow Fai... Anemia, Aplasti... Myelodysplastic... Hemoglobinuria,... Red-Cell Aplasi... Purpura, Thromb... Leukemia, Lymph... | 11 Years - | Office of Rare Diseases (ORD) | ||
| Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) | NCT00034684 | Leukemia Myelodysplastic... Leukemia, Myelo... Blast Crisis Leukemia, Lymph... | Farnesyl Protei... | 18 Years - | Merck Sharp & Dohme LLC | |
| Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS | NCT00025662 | Graft vs Host D... Myelodysplastic... Leukemia Leukemia, Myelo... Leukemia, Myelo... Leukemia, Lymph... Lymphoma Lymphoma, Mantl... Lymphoma, Non-H... Hodgkin Disease | RFT5-SMPT-dgA Isolex system | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) | NCT00361140 | Myelodysplastic... Myeloproliferat... Leukemia, Lymph... Myeloma Lymphoma | Busulfan Fludarabine | 16 Years - 65 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia | NCT00313079 | Leukemia, Lymph... Leukemia Acute Lymphocyt... | MAb 216 Vincristine | 18 Years - | Stanford University | |
| Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) | NCT03792256 | Leukemia, Lymph... Lymphoblastic L... T-cell Lymphoma T-cell Leukemia Recurrent Disea... Acute Leukemia | Palbociclib Cytarabine Methotrexate Hydrocortisone Doxorubicin Prednisolone Vincristine Pegaspargase Hydrocortisone Prednisone | 12 Months - 31 Years | Children's Oncology Group | |
| Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas | NCT00035022 | Leukemia, Lymph... Lymphoma | BCX-1777 | 0 Years - | BioCryst Pharmaceuticals | |
| T-cell and B-cell Depletion in Allogeneic Peripheral Blood Stem Cell Transplantation | NCT00306332 | Leukemia, Myelo... Leukemia, Lymph... Myelodysplastic... Leukemia, Myelo... Lymphoma | T-cell and B-ce... | 18 Years - 65 Years | Radboud University Medical Center | |
| Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS | NCT00025662 | Graft vs Host D... Myelodysplastic... Leukemia Leukemia, Myelo... Leukemia, Myelo... Leukemia, Lymph... Lymphoma Lymphoma, Mantl... Lymphoma, Non-H... Hodgkin Disease | RFT5-SMPT-dgA Isolex system | 18 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias | NCT01144793 | Leukemia, Lymph... Leukemia, Myelo... | 18 Years - | Stanford University | ||
| Treatment of Acute Lymphoblastic Leukemia (ALL) in Younger Adults | NCT00327678 | Leukemia, Lymph... | Rituximab Imatinib Mesyla... | 18 Years - 59 Years | Assistance Publique - Hôpitaux de Paris | |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia | NCT00270049 | Anemia Leukemia, Lymph... Leukemia, Lymph... Cancer Neoplasms Quality of Life | epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Study of Intravenous BCX-1777 in Relapsed or Refractory Aggressive T-Cell Leukemias or Lymphomas | NCT00035022 | Leukemia, Lymph... Lymphoma | BCX-1777 | 0 Years - | BioCryst Pharmaceuticals | |
| Busulfan Safety/Efficacy as Conditioning Prior to Hematopoietic Cell Transplantation (HCT) | NCT00361140 | Myelodysplastic... Myeloproliferat... Leukemia, Lymph... Myeloma Lymphoma | Busulfan Fludarabine | 16 Years - 65 Years | H. Lee Moffitt Cancer Center and Research Institute | |
| A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) | NCT05254743 | Chronic Lymphoc... Leukemia, Lymph... Leukemia, B-cel... Small Lymphocyt... | Pirtobrutinib Ibrutinib | 18 Years - | Eli Lilly and Company | |
| A Study of Enzastaurin in Patients With Leukemia | NCT00452257 | Leukemia, Lymph... | enzastaurin | 18 Years - | Eli Lilly and Company | |
| Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia | NCT00270049 | Anemia Leukemia, Lymph... Leukemia, Lymph... Cancer Neoplasms Quality of Life | epoetin alfa | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
